tiprankstipranks
Trending News
More News >
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market

Cogent Biosciences (COGT) Income Statement

Compare
695 Followers

Cogent Biosciences Income Statement

Last quarter (Q3 2025), Cogent Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cogent Biosciences's net income was $-80.93M. See Cogent Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 7.87M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -17.87M
Operating Expenses
$ 275.94M$ 208.13M$ 147.84M$ 75.55M$ 64.33M
Depreciation and Amortization
$ 4.35M$ 3.59M$ 5.88M$ 1.99M$ 720.00K
EBITDA
$ -271.59M$ -204.54M$ -141.96M$ -73.56M$ -34.57M
Operating Income
$ -275.94M$ -208.13M$ -147.84M$ -75.55M$ -82.20M
Other Income/Expenses
$ 20.08M$ 15.72M$ 7.60M$ 3.28M$ 7.39M
Pretax Income
$ -255.86M$ -192.41M$ -140.24M$ -72.27M$ -74.81M
Net Income
$ -255.86M$ -192.41M$ -140.24M$ -72.27M$ -74.81M
Per Share Metrics
Basic EPS
$ -2.46$ -2.42$ -2.26$ -1.85$ -6.00
Diluted EPS
$ -2.46$ -2.42$ -2.26$ -1.85$ -6.00
Weighted Average Shares Outstanding
103.86M 79.66M 58.74M 38.73M 11.08M
Weighted Average Shares Outstanding (Diluted)
103.86M 79.66M 58.74M 38.73M 11.08M
Currency in USD

Cogent Biosciences Earnings and Revenue History